Global Gene Editing Technologies Market Report 2023: Sector is Expected to Reach $16.37 Billion by 2032 at a CAGR of 27.5%
May 30, 2023 06:08 ET
|
Research and Markets
Dublin, May 30, 2023 (GLOBE NEWSWIRE) -- The "Gene Editing Technologies Market - A Global and Regional Analysis: Focus on Offering, Technology, Application, End User, and Region - Analysis and...
Gene Editing Global Market Report 2023: Rising Infectious Diseases Fuel the Sector
May 12, 2023 10:03 ET
|
Research and Markets
Dublin, May 12, 2023 (GLOBE NEWSWIRE) -- The "Gene Editing Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and...
AI (Artificial Intelligence) in Genomics Market Research Report 2023
March 31, 2023 05:38 ET
|
Research and Markets
Dublin, March 31, 2023 (GLOBE NEWSWIRE) -- The "AI in Genomics Market 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global AI in genomics market is expected to grow...
Global Gene Editing Partnering Analysis Report 2023: Terms and Agreements for 400+ Deals Signed Since 2010 by the World's Leading Healthcare Companies
March 09, 2023 05:19 ET
|
Research and Markets
Dublin, March 09, 2023 (GLOBE NEWSWIRE) -- The "Global Gene Editing Partnering Terms and Agreements 2010 to 2023" report has been added to ResearchAndMarkets.com's offering.The Global Gene Editing...
India Gene Editing Technology Market Databook Report 2023-2027: CRISPR, Meganucleases, TALEN, and ZFN Products, Delivery Method, Disease/Disorders, and Applications
March 03, 2023 06:58 ET
|
Research and Markets
Dublin, March 03, 2023 (GLOBE NEWSWIRE) -- The "India Gene Editing Technology Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's...
Intellia Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for NTLA-2002, an In Vivo CRISPR-Based Investigational Therapy for the Treatment of Hereditary Angioedema (HAE)
March 02, 2023 07:00 ET
|
Intellia Therapeutics, Inc.
CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapies...
Global Pharmacogenomics Market Report 2022: A $10.5 Billion Market by 2030 - Key Players are Extensively Involved in Seeking Approvals and Product Launches to Remain Competitive
February 28, 2023 07:53 ET
|
Research and Markets
Dublin, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Pharmacogenomics Market Growth Analysis by Service, Technology, Application, End-user - Industry Revenue Estimation and Demand Forecast to 2030"...
China Gene Editing Technology Market Databook Report 2023: Business and Investment Opportunities to 2027
February 27, 2023 10:33 ET
|
Research and Markets
Dublin, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The "China Gene Editing Technology Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's...
Global Gene Editing Technology Market Report 2023 Featuring bluebird, Beam, Caribou Bio, Cellectis, Allogene, Intellia TX, Editas Medicine, Verve, AstraZeneca, Merck, & Thermo Fisher Scientific
February 21, 2023 11:43 ET
|
Research and Markets
Dublin, Feb. 21, 2023 (GLOBE NEWSWIRE) -- The "Global Gene Editing Technology Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial...
Gene Therapy Global Market Report 2023: Increasing Prevalence of Cancer Fuels Demand
February 16, 2023 08:53 ET
|
Research and Markets
Dublin, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type...